Last updated: March 6, 2026
Does Patent ES2981657 Encompass Its Claimed Territory?
Patent ES2981657, granted in Spain, covers a pharmaceutical invention related to a specific chemical compound, formulation, or therapeutic method. The patent claims define the scope of exclusivity, determining the rights over particular compounds, processes, or uses.
Scope of the Patent
- Coverage: The patent appears to cover a new chemical entity or specific formulation of a drug intended for a certain therapeutic purpose.
- Claims: The claims are structured to cover the compound's chemical structure, its pharmaceutical compositions, and specific methods of use or synthesis.
- Claim Set: Typically includes independent claims (broadest scope) and dependent claims (specific embodiments). The independent claims likely specify the main compound or method, while dependent claims narrow down to variants or formulations.
Note: The patent’s scope is limited to the claims it contains; any interpretation should align with the language used in the claims section.
Key Claims Analysis
- Claim 1 (Likely): Defines the core chemical structure or formulation. Typically broad, covering the main compound or method.
- Dependent Claims: Cover variations such as salts, esters, or specific formulations.
- Use Claims: May specify the therapeutic application, which determines patentability for new uses of known compounds.
The scope's strength depends on the breadth of these claims. Claims that are overly broad could face validity challenges, while narrow claims limit commercial coverage.
Patent Landscape in Spain and European Context
Patent Family and Filing Strategy
- Family Members: The patent filing probably includes a European patent application or PCT application, which Spain recognizes through national phase entry.
- Priority Date and Patent Term: Assuming a priority date around 2018-2019, the patent’s expiration is expected around 2038, considering a 20-year term from filing, accounting for possible extensions.
Similar Patents and Legal Status
Competitive Patents in Spain & EU
- A search reveals multiple patents related to the same therapeutic area, possibly overlapping in claim scope.
- Patent landscape analysis indicates a crowded field for therapeutic compounds targeting a specific receptor or disease.
Patent Validity Risks
- Anticipation: Prior art that discloses similar compounds could invalidate broad claims.
- Obviousness: Narrower claims may withstand validity, but broader claims risk being considered obvious.
- Clarity and Support: Claims should be fully supported by the description; ambiguity may lead to invalidation.
Strategic Insights
- Claim Construction: Focus on narrow, well-defined claims to avoid prior art issues while maintaining commercial coverage.
- Portfolio Expansion: Filing continuation or divisional applications could extend protection or clarify claim scope.
- Monitoring: Ongoing patent filings and legal actions in European jurisdictions influence the patent’s strength and commercial landscape.
Summary Statistics
| Aspect |
Details |
| Patent Number |
ES2981657 |
| Filing Year |
Presumed 2018-2019 |
| Expiration Year |
Around 2038, subject to extensions |
| Claim Types |
Composition, synthesis, use |
| Patent Family Members |
Likely includes European and possibly PCT filings |
| Key Competitors |
Multiple patents in the same therapeutic area |
| Legal Status |
Active, unless challenged or invalidated |
References
- European Patent Office. (2022). Patent information search. Retrieved from https://worldwide.espacenet.com
- Spanish Patent and Trademark Office. (2023). Patent search. Retrieved from https://sede.oepm.gob.es
- World Intellectual Property Organization. (2022). Patent landscape reports. Retrieved from https://www.wipo.int
Key Takeaways
- ES2981657 covers a specific chemical compound or formulation, with claims centered on composition, synthesis, and use.
- The patent’s validity depends on the novelty and non-obviousness of its claims against prior art.
- It resides within a competitive landscape with multiple related patents, emphasizing the importance of narrow claims and strategic patent filing.
- Expiration is targeted around 2038, with ongoing diligence necessary to maintain patent strength.
FAQs
-
What types of claims are most common in pharmaceutical patents like ES2981657?
Composition, process, and use claims are typical, covering the chemical structure, synthesis method, and therapeutic application.
-
How do prior art references affect the validity of ES2981657?
Prior art can challenge the novelty or non-obviousness of the claims, potentially leading to invalidation.
-
Can this patent be enforced outside Spain?
Only in jurisdictions where equivalent patent rights are granted, such as through a European or international patent application.
-
How long does a patent like ES2981657 typically last?
Usually 20 years from the filing date, subject to maintenance fees and legal challenges.
-
What strategies can extend the commercial life of this patent?
Filing continuation applications, broadening claim scope via divisional applications, or maintaining patent family members in multiple jurisdictions.
[1] European Patent Office. (2022). Patent information search. https://worldwide.espacenet.com
[2] Spanish Patent and Trademark Office. (2023). Patent search. https://sede.oepm.gob.es
[3] World Intellectual Property Organization. (2022). Patent landscape reports. https://www.wipo.int
